Herb-Herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice and Future Perspectives

Herb-herb combinations have been used in Chinese medicine practice for thousands of years, yet scientific evidence of their therapeutic benefits is lacking. With increasing interest in shifting from the one-drug-one-target paradigm to combination therapy or polypharmacy to achieve therapeutic benefits for a number of diseases, there is momentum to explore new knowledge by tapping the past empirical experiences of herb-herb combinations. This review presents an overview of the traditional concept and practice of herb-herb combination in Chinese medicine, and highlights the available scientific and clinical evidence to support the combined use of herbs. It is hoped that such information would provide a lead for developing new approaches for future therapeutic advancement and pharmaceutical product development. Very likely modern technologies combined with innovative research for the quality control of herbal products, identification of active components and understanding of the molecular mechanism, followed by well-designed animal and clinical studies would pave the way in advancing the wealth of empirical knowledge from herb-herb combination to new therapeutic modalities.

[1]  Huldrych F. Günthard,et al.  Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. , 2012, JAMA.

[2]  Peng-lin Yang,et al.  Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension: A Systematic Review and Meta-Analysis , 2013, Evidence-based complementary and alternative medicine : eCAM.

[3]  Qiuyan Liu.  Triptolide and its expanding multiple pharmacological functions. , 2011, International immunopharmacology.

[4]  D. Chang,et al.  Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose. , 2009, The Cochrane database of systematic reviews.

[5]  Chen Lv,et al.  Synergistic interaction between total glucosides and total flavonoids on chronic constriction injury induced neuropathic pain in rats , 2013, Pharmaceutical biology.

[6]  Hao Wu,et al.  [Study on irritation of calcium oxalate crystal in raw Pinellia ternata]. , 2006, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[7]  H. Vetter,et al.  New perspectives for synergy research with the "omic"-technologies. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  Yingdong Zhao,et al.  Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment , 2011, BMC Medical Genomics.

[9]  Zhong Zuo,et al.  Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use , 2005, Journal of clinical pharmacology.

[10]  Shiew-Mei Huang,et al.  Botanical-Drug Interactions: A Scientific Perspective , 2012, Planta Medica.

[11]  A. Panossian,et al.  Comparative study of Rhodiola preparations on behavioral despair of rats. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  M. Massari,et al.  Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review , 2011, PloS one.

[13]  Amalio Telenti,et al.  Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel , 2010 .

[14]  D. Mitchison.  Prevention of drug resistance by combined drug treatment of tuberculosis. , 2012, Handbook of experimental pharmacology.

[15]  S. Dai,et al.  A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety , 2011, Rheumatology International.

[16]  K. Fung,et al.  Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing. , 2012, Journal of ethnopharmacology.

[17]  B. Gurley,et al.  Pharmacokinetic Herb-Drug Interactions (Part 1): Origins, Mechanisms, and the Impact of Botanical Dietary Supplements , 2012, Planta medica.

[18]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[19]  Z. Debyser,et al.  Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF , 2012, Expert opinion on pharmacotherapy.

[20]  C. Cho,et al.  Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells. , 2008, Journal of ethnopharmacology.

[21]  J. Kwong,et al.  Herbal medicines for viral myocarditis. , 2012, The Cochrane database of systematic reviews.

[22]  K. Bone,et al.  Herbal products: active constituents, modes of action and quality control , 2000, Nutrition Research Reviews.

[23]  M. Guiguet,et al.  Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study , 2012, AIDS.

[24]  U. Mrowietz,et al.  Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. , 2012, British journal of clinical pharmacology.

[25]  D. Kennedy,et al.  Acute, dose‐dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand , 2002, Human psychopharmacology.

[26]  Hao Xu,et al.  Traditional Chinese Herbal Products for Coronary Heart Disease: An Overview of Cochrane Reviews , 2012, Evidence-based complementary and alternative medicine : eCAM.

[27]  D. Wheatley.  Stress‐induced insomnia treated with kava and valerian: singly and in combination , 2001, Human psychopharmacology.

[28]  I. Benzie,et al.  DNA Protective Effect of Ginseng and the Antagonistic Effect of Chinese Turnip: A Preliminary Study , 2011, Plant foods for human nutrition.

[29]  T. He,et al.  A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity. , 2009, Oncology reports.

[30]  H. Wu,et al.  [The experiment research of ginger detoxification to Rhizoma Pinelliae]. , 1998, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[31]  Jeffrey Bjoraker,et al.  A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906 , 2010, Chinese medicine.

[32]  Gong Le.  Inflammation-induced effect of toxic raphides from Pinellia ternata , 2012 .

[33]  P. Fasinu,et al.  An Overview of the Evidence and Mechanisms of Herb–Drug Interactions , 2012, Front. Pharmacol..

[34]  H. Wagner,et al.  Synergy research: approaching a new generation of phytopharmaceuticals. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[35]  Shao Li,et al.  Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network , 2010, BMC Bioinformatics.

[36]  Jianhui Rong,et al.  Genome-wide biological response fingerprinting (BioReF) of the Chinese botanical formulation ISF-1 enables the selection of multiple marker genes as a potential metric for quality control. , 2007, Journal of ethnopharmacology.

[37]  Li-jun Zhu,et al.  [Modulation of the activities and mRNA expression of cytochrome P450 isoenzymes in rat liver by Panax gingseng and coadministration with Veratrum nigrum]. , 2004, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[38]  Y. Tjong,et al.  Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation , 2010, Chinese medicine.

[39]  M. Yuen,et al.  Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials , 2012, Chinese Medicine.

[40]  N. Grant,et al.  Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[41]  E. Williamson,et al.  Synergy and other interactions in phytomedicines. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[42]  C. Xue,et al.  The theoretical framework of chinese medicine , 2003 .

[43]  B. Gurley,et al.  Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance , 2012, Planta medica.

[44]  Y. Yen,et al.  Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma. , 2009, Anticancer research.

[45]  Cristiano Colalto.  Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment. , 2010, Pharmacological research.

[46]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[47]  C. Xue,et al.  Oral Chinese herbal medicine for improvement of quality of life in patients with stable chronic obstructive pulmonary disease: a systematic review. , 2012, Journal of alternative and complementary medicine.

[48]  Benjamin J. Whalley,et al.  Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects? , 2003 .

[49]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[50]  A. Izzo.  Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data , 2012, Medical Principles and Practice.

[51]  Yanqing Sun,et al.  Pharmacokinetics of Geniposide in Zhi‐Zi‐Hou‐Pu Decoction and in Different Combinations of its Constituent Herbs , 2012, Phytotherapy research : PTR.

[52]  R. Hermann,et al.  Clinical Evidence of Herbal Drugs As Perpetrators of Pharmacokinetic Drug Interactions , 2012, Planta Medica.

[53]  G. Sethi,et al.  Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. , 2011, Cancer letters.

[54]  Shufeng Zhou,et al.  Herb-drug interactions and mechanistic and clinical considerations. , 2012, Current drug metabolism.

[55]  L. Zhou,et al.  Shengmai (a traditional Chinese herbal medicine) for heart failure. , 2007, The Cochrane database of systematic reviews.

[56]  P. Rasoanaivo,et al.  Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions , 2011, Malaria Journal.

[57]  K. Shadan,et al.  Available online: , 2012 .

[58]  Ting Gao,et al.  Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant Species , 2010, PloS one.

[59]  A. Salminen,et al.  Celastrol: Molecular targets of Thunder God Vine. , 2010, Biochemical and biophysical research communications.

[60]  David R. Jones,et al.  Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer. , 2013, Anti-cancer agents in medicinal chemistry.

[61]  S. Tsui,et al.  An integrated web medicinal materials DNA database: MMDBD (Medicinal Materials DNA Barcode Database) , 2010, BMC Genomics.

[62]  J. Sarris,et al.  ‘Omic’ Genetic Technologies for Herbal Medicines in Psychiatry , 2012, Phytotherapy research : PTR.

[63]  Xu Wu,et al.  Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy. , 2012, Journal of ethnopharmacology.

[64]  Y. Kong.  Huangdi Neijing: A Synopsis with Commentaries , 2010 .

[65]  G. Lewith,et al.  Chinese herbal medicines for hypercholesterolemia. , 2011, The Cochrane database of systematic reviews.

[66]  T. Efferth,et al.  Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. , 2011, Current drug targets.

[67]  P. Houghton.  Synergy and polyvalence : paradigms to explain the activity of herbal products , 2009 .